Sage Journals: Discover world-class research

Retricted access

Research article

First published 2019-8

Comparing Anti–Factor Xa and Activated Partial Thromboplastin Levels for Monitoring Unfractionated Heparin

Rebekah A. Wahking, Rachel H. Hargreaves, Sean M. Lockwood [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2023-7

Concordance Between Active Partial Thromboplastin Time and Anti-Factor Xa Assays in Neurocritically Ill Patients Receiving Subcutaneous Heparin Prophylaxis

Grace Shinn, Karen Berger, David Roh [...]

The Neurohospitalist

Open access

Research article

First published 2018-3

Performance of Anti-Factor Xa Versus Activated Partial Thromboplastin Time for Heparin Monitoring Using Multiple Nomograms

Emily Whitman-Purves, James C. Coons, Taylor Miller [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 2020-11

Anti–Factor Xa Activity of Fixed-Dose Fondaparinux in Low-Body-Weight Patients With Acute Coronary Syndrome

Wanwarang Wongcharoen, Nualnit Tantisirivit, Lalita Norasetthada [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2025-10

Unfractionated heparin monitoring by anti-factor Xa versus activated partial thromboplastin time strategies during venoarterial extracorporeal life support

Iris Feng, Tanner R. Powley, Christine G. Yang [...]

Perfusion

Retricted access

Research article

First published 2021-5

Performance Assessment of a Multifaceted Unfractionated Heparin Dosing Protocol in Adult Patients on Extracorporeal Membrane Oxygenator

Abdulrazaq Al-Jazairi, Shahad Raslan, Rayd Al-mehizia [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2022-12

Comparison of Managing Factor Xa Inhibitor to Unfractionated Heparin Transitions by aPTT Versus a Treatment Guideline Utilizing Heparin Anti-Xa Levels

Scott J. Dingus, Alex R. Smith, William E. Dager [...]

Annals of Pharmacotherapy

Retricted access

Review article

First published 2019-11

Nonhemostatic Activities of Factor Xa: Are There Pleiotropic Effects of Anti-FXa Direct Oral Anticoagulants?

Styliani Papadaki, Alexandros D. Tselepis

Angiology

Open access

Research article

First published 2022

Patients’ Plasma Activity of Heparin,low-Molecular-Weight Heparin or no Anticoagulants on Urine Based DOAC Test Strips

Job Harenberg, Svetlana Hetjens, Christel Weiss

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 2023-2

Evaluation of a Multimodal Heparin Laboratory Monitoring Protocol in Adult Extracorporeal Membrane Oxygenation Patients

Kalynn A. Northam, Bobbie Nguyen, Sheh-Li Chen [...]

Journal of Pharmacy Practice

Search results